Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-08 4:16 pm Sale | 13G | PHARVARIS N V REGISTERED PHVS | LSP V Cooperatieve U.A. | 3,556,805 6.8% | -50,761 (-1.41%) | View |
| 2023-02-24 07:00 am Unchanged | 13D | IMMUNIC INC IMUX | LSP V Cooperatieve U.A. | 2,162,782 4.9% | 0 (Unchanged) | View |
| 2023-02-10 07:06 am Sale | 13G | ORPHAZYME A/S ADR ORPH | LSP V Cooperatieve U.A. | 2,426,711 6.9% | -169,450 (-6.53%) | View |
| 2022-02-03 4:18 pm Purchase | 13G | PHARVARIS N V REGISTERED PHVS | LSP V Cooperatieve U.A. | 3,607,566 10.9% | 3,607,566 (New Position) | View |
| 2022-02-03 4:16 pm Sale | 13G | ORPHAZYME A/S ADR ORPH | LSP V Cooperatieve U.A. | 2,596,161 7% | -114,668 (-4.23%) | View |
| 2022-02-03 4:16 pm Unchanged | 13D | ELOXX PHARMACEUTICALS INC ELOX | LSP V Cooperatieve U.A. | 2,953,673 3.4% | 0 (Unchanged) | View |
| 2021-02-08 4:15 pm Purchase | 13G | ORPHAZYME A/S ADR ORPH | LSP V Cooperatieve U.A. | 2,710,829 7.8% | 2,710,829 (New Position) | View |
| 2020-09-04 4:15 pm Unchanged | 13D | IMMUNIC INC IMUX | LSP V Cooperatieve U.A. | 2,162,782 10.4% | 0 (Unchanged) | View |
| 2020-03-13 4:15 pm Purchase | 13D | ELOXX PHARMACEUTICALS INC ELOX | LSP V Cooperatieve U.A. | 2,953,673 7.4% | 300,000 (+11.31%) | View |